Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203333 · ClinicalTrials.gov registry record
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 19
- Enrollment target
NCT00203333: Completed study, sponsored by Thomas Jefferson University.
NCT00203333 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00203333 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
People with epilepsy are at a higher risk for sudden unexpected death than the general population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is particularly high for those with refractory epilepsy. Several lines of evidence support a cardiac mechanism for SUDEP. This study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in this population and 2. whether these are increased above the general population in the same age group. Additionally, these data will be correlated to specific clinical data, including seizure history, anticonvulsant medications, and any accompanying clinical symptoms.
Interventions
- DEVICE Medtronic REVEAL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2002-04 |
| Est. Completion | 2010-01 |
What the finished NCT00203333 record still lists
NCT00203333 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Medtronic REVEAL is the first listed.
NCT00203333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00203333 about?
NCT00203333 is a clinical study titled "Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death". People with epilepsy are at a higher risk for sudden unexpected death than the general population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is particularly high for those with...
What is the current status of trial NCT00203333?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2002-04. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00203333?
The interventions under investigation include: Medtronic REVEAL (DEVICE).
Who is sponsoring clinical trial NCT00203333?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia